Delve into the essential read on osteoporosis diagnostics by Dr. Venu Nemani, MD, PhD. Explore the crucial trio of testing modalities—DXA, FRAX, and opportunistic CT scans—used to detect this silent bone disease. Learn about the recommended frequency of these tests, their availability, and which healthcare professionals are qualified to order them. For the full insights, read the full article: https://ow.ly/zcBL50R8mPX #BoneHealth #Research #SpineHealth #Osteoporosis
National Spine Health Foundation’s Post
More Relevant Posts
-
According to many authors, the incidence of osteomyelitis in the world is increasing, doubling its rate between the 1960s and the 2010s. Despite the growing number of publications in this area, this disease still represents a major challenge for orthopedists around the world. This study aimed to highlight the continued importance and utility of plain radiography as a rapid, cost-effective, and readily accessible examination in the diagnostic process. Our study shows that radiographic findings in chronic osteomyelitis were universally observed in all patients studied, demonstrating a high degree of concordance among specialists. #osteomyelitis, #boneinfection, #musculoskeletaldisorders https://lnkd.in/ez7ypaqK
To view or add a comment, sign in
-
📢New #Research: "Association between 82Rb positron emission tomography-derived regional myocardial blood flow, severity of angiographic coronary artery stenosis, and mortality in patients with chest pain" 👥By Cesia Gallegos et al. Read #article here: https://lnkd.in/gV35h5pM
To view or add a comment, sign in
-
🚨 Big news from Vesalio! 🚨 We’re launching a U.S. clinical study for our pVasc™ Thrombectomy System, designed to address the challenges of removing thromboemboli in acute limb ischemia (#ALI). The #pVasc Study will gather real-world data to help optimize revascularization strategies in supporting patients with peripheral arterial disease (#PAD). We’re looking forward to connecting with industry experts at the upcoming TCT, VIVA, and VEITH conferences to share insights on our advancements and discuss the future of vascular health. Read Press Release: https://lnkd.in/g9ysv9Wd This is just the beginning—stay tuned for more updates as we continue pushing the boundaries of endovascular innovation! 💡 #DoTheDropZone #PeripheralThrombectomy #AcuteLimbIschemia #PeripheralArterialDisease
To view or add a comment, sign in
-
Register for Session 2 of the educational webinar: 'Key Updates, Including ePV, for Managing Sepsis and Septic Shock' by Nova Biomedical With Sepsis prognosis being improved through advances in critical care management, mortality from sepsis remains high. March 28, 2024 | 1:00 PM EST Register here https://iii.hm/1paz #sepsisawareness #criticalcare #mayoclinic
To view or add a comment, sign in
-
Our selected "Article of the Month": The costs analysis related to COPD, evaluated in a representative sample compared to individuals without the disease, informs that in 2019 the overall estimate of costs incurred was equal to $31.3 billion. This figure is destined to double within the next 10 years, albeit with significant national geographical differences. This evidence actualizes the enormous economic burden determined by this pathology and highlights how the complexity of the care required by these patients makes action planning necessary to rationalize resources. https://lnkd.in/grx5yTDG
To view or add a comment, sign in
-
Do you conduct research on clinical advancements in vascular disease? 🩸 This is your call to submit your abstract on topics like thrombosis, diabetes-related vascular issues, new lipid-lowering therapies, and the role of digital health in patient care. With only one week left until the deadline, now’s the time to share your insights and contribute to the future of vascular disease care at #EASCongress2025! ➡️ https://lnkd.in/dqtw6sSE #CardiovascularHealth #Cardiovascular #AtherosclerosisResearch #HeartHealthExperts
To view or add a comment, sign in
-
At #AHA24, we sat down with Ahmad Masri, MD, of Oregon Health & Science University, about how recent advances in therapy and diagnosis have contributed to the changing risk profile of patients with transthyretin amyloid cardiomyopathy (ATTR-CM) in the US. Learn more about the study: https://lnkd.in/gV4FzucN #Cardiomyopathy
To view or add a comment, sign in
-
The #CortisolTestCassette (Serum/Plasma) is a vital diagnostic tool for assessing cortisol levels, which is crucial in identifying diseases such as Cushing's syndrome and Addison's disease. Abnormal cortisol levels may lead to serious health issues, including chronic fatigue, muscle weakness and metabolic disorders, significantly impacting an individual's quality of life. This test utilizes a fluorescence immunoassay for the precise quantitative determination of cortisol in human serum and plasma, providing results within a test range of 50 nmol/L to 1000 nmol/L. The advantages of the Cortisol Test Cassette include its accuracy, ease of use and rapid results, making it an essential resource for healthcare professionals. Ultimately, it plays a significant role in early diagnosis and management of cortisol-related conditions, enhancing patient care and improving health outcomes. https://lnkd.in/gAFTXvv7 #CortisolTest #AddisonsDisease #FluorescenceImmunoassay #PatientCare #MetabolicDisorders #AllTest #Innovation
To view or add a comment, sign in
-
Why should diagnostics of acute promyelocytic leukaemia (APL) be done quickly❔ Prompt diagnosis of acute promyelocytic leukaemia is critical to saving lives. Quick identification enables: ☑️ Immediate treatment ☑️ Prevention of severe complications ☑️ Tailored and effective care Every minute counts in APL diagnosis. Let's prioritise efficient processes to improve patient outcomes. Learn more about APL in this month's scientific calendar case. 🔗 https://lnkd.in/dyv3e7MM #sysmex #sysmexnordic #bloodcancer
To view or add a comment, sign in
-
An interesting article by myself and Hsuan (Tina) Chou, PhD discussing how breath analysis could revolutionise cystic fibrosis management. Give it a read here!
In a new article in collaboration with Technology Networks Hsuan (Tina) Chou, PhD and Lucy Godbeer of Owlstone Medical explore how breath analysis could enable more comfortable and non-invasive sampling for cystic fibrosis patients. Click the link to find out more about the complexities of cystic fibrosis, the need for disease monitoring, and the potential of breath analysis to improve long-term management. https://ow.ly/VL2c50RGOzw #cysticfibrosis #diseasemanagement #breath #non-invasive
To view or add a comment, sign in
1,271 followers
CEO of the National Spine Health Foundation
9moThank you for sharing your expertise Venu Nemani, MD, PhD